“…However,since both pH and GSH levels between cancerous and normal tissues are not very different (pH 6.5-6.9 for tumor microenvironment and 7.4 for normal tissues; [25] intracellular GSH levels for cancer and normal cells are in 2-13 mM), [26,27] the efficacy of the pHor GSH-based fluorescent probes still remains challenging, and indeed only alimited number of examples of success have been reported to date. [28][29][30][31][32][33][34][35] Conversely,c ancer cells have approximately ten times higher ROS(including HOC,O 2 C À ,H 2 O 2 ,ClO À ,ONOO À , 1 O 2 , etc. )l evel than normal cells, [36][37][38][39] and thus the ROS-responsive fluorescent probes,i np rinciple,s hould possess higher selectivity for cancer cells/tissues over normal ones.I nf act, the characteristic has been utilized to fabricate the ROSsensitive drug delivery systems for cancer therapy,s uch as those consisting of ROS-responsive polymers.…”